[논문]Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Boni, Carolina; Janssen, Harry L.A.; Rossi, Marzia; Yoon, Seung Kew; Vecchi, Andrea; Barili, Valeria; Yoshida, Eric M.; Trinh, Huy; Rodell, Timothy C.; Laccabue, Diletta; Alfieri, Arianna; Brillo, Federica; Fisicaro, Paola; Acerbi, Greta; Pedrazzi, Giuseppe; Andreone, Pietro; Cursaro, Carmela; Margotti, Marzia; Santoro, Rosanna; Piazzolla, Valeria; Brunetto, Maurizia R.; Coco, Barbara; Cavallone, Daniela; Zhao, Yang; Joshi, Adarsh; Woo, Jacky; Lau, Audrey H.; Gaggar, Anuj; Subramanian, G. Mani; Massetto, Benedetta; Fung, Scott; Ahn, Sang Hoon; Ma, Xiaoli; Mangia, Alessandra; Ferrari, Carlo

doi:10.1053/j.gastro.2019.03.044

[해외논문] Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 원문보기

Gastroenterology, v.157 no.1, 2019년, pp.227 - 241.e7

Boni, Carolina (Laboratory of Viral Immunopathology, Department of Medicine and Surgery, University of Parma and Unit of Infectious Diseases and Hepatology, Azienda-Ospedaliero-Universitaria of Parma) , Janssen, Harry L.A. (Toronto Center for Liver Diseases, University Health Network) , Rossi, Marzia (Laboratory of Viral Immunopathology, Department of Medicine and Surgery, University of Parma and Unit of Infectious Diseases and Hepatology, Azienda-Ospedaliero-Universitaria of Parma) , Yoon, Seung Kew (The Catholic University of Korea, College of Medicine) , Vecchi, Andrea (Laboratory of Viral Immunopathology, Department of Medicine and Surgery, University of Parma and Unit of Infectious Diseases and Hepatology, Azienda-Ospedaliero-Universitaria of Parma) , Barili, Valeria (Laboratory of Viral Immunopathology, Department of Medicine and Surgery, University of Parma and Unit of Infectious Diseases and Hepatology, Azienda-Ospedaliero-Universitaria of Parma Yoshida, Eric M. , Trinh, Huy , Rodell, Timothy C. , Laccabue, Diletta , Alfieri, Arianna , Brillo, Federica , Fisicaro, Paola , Acerbi, Greta , Pedrazzi, Giuseppe , Andreone, Pietro , Cursaro, Carmela , Margotti, Marzia , Santoro, Rosanna , Piazzolla, Valeria , Brunetto, Maurizia R. , Coco, Barbara , Cavallone, Daniela , Zhao, Yang , Joshi, Adarsh , Woo, Jacky , Lau, Audrey H. , Gaggar, Anuj , Subramanian, G. Mani , Massetto, Benedetta , Fung, Scott , Ahn, Sang Hoon , Ma, Xiaoli , Mangia, Alessandra , Ferrari, Carlo

Abstract ▼ AI-Helper

Background & Aims One strategy to treat chronic hepatitis B virus (HBV) infection could be to increase the functions of virus-specific T cells. We performed a multicenter phase 2 study to evaluate the safety and efficacy of GS-4774, a yeast-based therapeutic vaccine engineered to express HBV antigens, given with tenofovir disoproxil fumarate (TDF) to untreated patients with chronic HBV infection. Methods We performed an open-label study at 34 sites in Canada, Italy, New Zealand, Romania, South Korea, and United States from July 2014 to August 2016. Adults who were positive for HB surface antigen (HBsAg) > 6 months and levels of HBV DNA ≥2000 IU/mL who had not received antiviral treatment for HBV within 3 months of screening were randomly assigned (1:2:2:2) to groups given oral TDF 300 mg daily alone (n = 27; controls) or with 2, 10, or 40 yeast units GS-4774 (n = 168), administered subcutaneously every 4 weeks until week 20 for a total of 6 doses. Blood samples were collected and analyzed and patients received regular physical examinations. Efficacy was measured by decrease in HBsAg from baseline to week 24. Specific responses to HBV (production of interferon gamma [IFNG], tumor necrosis factor [TNF], interleukin 2 [IL2], and degranulation) were measured in T cells derived from 12 HBeAg-negative patients with genotype D infections, after overnight or 10 days of stimulation of peripheral blood mononuclear cells with peptides from the entire HBV proteome. T-regulatory cells were analyzed for frequency and phenotype. Data from studies of immune cells were compared with data on reductions in HBsAg, HBV DNA, and alanine aminotransferase in blood samples from patients. Results GS-4774 was safe and well tolerated but did not produce significant decreases in levels of HBsAg. Production of IFNG, TNF, and IL2 increased significantly at weeks 24 and 48, compared with baseline, in HBV-specific CD8+ T cells from patients given GS-4774 but not from controls. GS-4774 had greater effects on CD8+ than CD4+ T cells, which were not affected at all or very weakly by TDF with or without GS-4774. GS-4774 did not affect responses of T cells to other viruses tested. HBV core peptides induced the greatest production of IFNG by T cells following overnight stimulation, whereas HBV envelope antigens did not induce a response. Following 10 days of stimulation, production of IFNG and TNF increased with time of exposure to GS-4774; the greatest levels of responses were to HBV envelope antigens followed by core and polymerase peptides. We observed a correlation in patients given GS-4774 between increased T-cell functions and reductions in numbers of T-regulatory cells. Conclusions In a phase 2 study of patients with chronic HBV infection given TDF with or without GS-4774, we found that vaccination can increase production of IFNG, TNF, and IL2 by CD8+ T cells exposed to antigenic peptides, with little effect on CD4+ T cells. Although GS-4774 did not reduce levels of HBsAg in patients, its strong immune stimulatory effect on CD8+ T cells might be used in combination with other antiviral agents to boost the antivirus immune response. Clinicaltrials.gov no: NCT02174276. Graphical abstract [DISPLAY OMISSION]

주제어

참고문헌 (25)

J Hepatol Lampertico 67 370 2017 10.1016/j.jhep.2017.03.021 EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

상세보기
Liver Int Saitta 35 2311 2015 10.1111/liv.12807 Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma

상세보기
Sci Transl Med Wooddell 9 eaan0241 2017 10.1126/scitranslmed.aan0241 RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg

상세보기
J Hepatol Durantel 64 Suppl 1 S117 2016 10.1016/j.jhep.2016.02.016 New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus

상세보기
Curr Opin Virol Seeger 30 18 2018 10.1016/j.coviro.2018.01.009 Control of viral transcripts as a concept for future HBV therapies

상세보기
J Hepatol Bertoletti 64 S71 2016 10.1016/j.jhep.2016.01.026 Adaptive immunity in HBV infection

상세보기
Best Pract Res Clin Gastroenterol Gehring 31 337 2017 10.1016/j.bpg.2017.05.004 New treatments to reach functional cure: rationale and challenges for emerging immune-based therapies

상세보기
Curr Opin Virol Dembek 30 58 2018 10.1016/j.coviro.2018.04.003 Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccination

상세보기
Vaccine Gaggar 32 4925 2014 10.1016/j.vaccine.2014.07.027 Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study

상세보기
PLoS One King 9 e101904 2014 10.1371/journal.pone.0101904 A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T-cells in mice and activates human T-cells recognizing epitopes linked to viral clearance

상세보기
J Hepatol Lok 65 509 2016 10.1016/j.jhep.2016.05.016 Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B

상세보기
Nat Med Stubbs 7 625 2001 10.1038/87974 Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity

상세보기
Vaccine Cereda 29 4992 2011 10.1016/j.vaccine.2011.04.101 Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T-cells and enhances the ratio of antigen-specific effectors to regulatory T-cells

상세보기
Clin Immunol Benwell 134 178 2010 10.1016/j.clim.2009.09.013 Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells

상세보기
Hepatology Terrault 63 261 2016 10.1002/hep.28156 AASLD guidelines for treatment of chronic hepatitis B

상세보기
Gastroenterology Boni 143 963 2012 10.1053/j.gastro.2012.07.014 Restored function of HBV-specific T-cells after long-term effective therapy with nucleos(t)ide analogues

상세보기
Nat Rev Immunol Wherry 15 486 2015 10.1038/nri3862 Molecular and cellular insights into T-cell exhaustion

상세보기
Immunity Attanasio 44 1052 2016 10.1016/j.immuni.2016.04.022 Costimulatory and coinhibitory receptor pathways in infectious disease

상세보기
Curr Opin Virol Fisicaro 30 1 2018 10.1016/j.coviro.2018.01.003 Strategies to overcome HBV-specific T-cell exhaustion: checkpoint inhibitors and metabolic re-programming

상세보기
Gastroenterology Knolle 146 1193 2014 10.1053/j.gastro.2013.12.036 Hepatic immune regulation and its involvement in viral hepatitis infection

상세보기
World J Gastroenterol Billerbeck 13 4858 2007 10.3748/wjg.v13.i36.4858 Regulatory T-cells in viral hepatitis

상세보기
Immunity Miyara 30 899 2009 10.1016/j.immuni.2009.03.019 Functional delineation and differentiation dynamics of human CD4+ T-cells expressing the FoxP3 transcription factor

상세보기
J Clin Invest Gehring 123 3766 2013 10.1172/JCI66043 Mobilizing monocytes to cross-present circulating viral antigen in chronic infection

상세보기
Gastroenterology Boni 154 1764 2018 10.1053/j.gastro.2018.01.030 TLR7 agonist increases responses of hepatitis B virus-specific T cells and natural killer cells in patients with chronic hepatitis B treated with nucleos(t)ide analogues

상세보기
Curr Opin Virol Levrero 30 80 2018 10.1016/j.coviro.2018.04.006 Perspectives and limitations for nucleo(t)side analogs in future HBV therapies

상세보기

LOADING...

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

[해외논문] Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (25)

이 논문을 인용한 문헌

연구과제 타임라인

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

연관된 기능

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트

연합인증

[해외논문] Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (25)

이 논문을 인용한 문헌

연구과제 타임라인

전체(0) 논문(0) 특허(0) 보고서(0)

전체(0) 논문(0) 특허(0) 보고서(0)

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

연관된 기능

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트